BrainChild Bio
BrainChild Bio is harnessing the power of CAR-T cell technology for tumors in the central nervous system.
Biotechnology Research·0 Followers
Overview
We are a kids-first, clinical-stage biotechnology company focused on harnessing the power of CAR-T cell technology for tumors n the central nervous system (CNS), prioritizing pediatrics with plans to expand our technology to adult indications. We are building a platform to optimize the application of CAR-T technology in CNS tumors-- prioritizing diffuse intrinsic pontine glioma (DIPG) with plans to expand to other pediatric and adult brain tumors, including brain metastases....See more
Website
https://brainchildbio.com/Industry
Biotechnology Research
Company size
55 employees
Headquarters
Seattle, WA
Upgrade to view team
View current team members and their roles
Access founders information
Request warm introductions
Funding Rounds (1)
$116.0M • Series A
Announced on 9/8/2026
Open Positions(0)
No open jobs posted for this organization yet.
Company Updates
No updates available yet.